• Biotechnology and Bioprocess Engineering:BBE
• /
• 제6권3호
• /
• pp.167-172
• /
• 2001

Staphylokinase (SAK) was produced in B. subtilis using two different promoter systems, i.e. the P43 and sacB promoters. To maximize SAK expression in B. subtilis, fermentation control strategies for each promoter were examined. SAK, under P43, a vegetative promoter transcribed mainly by $\sigma$(sup)B containing RNA polymerase, was overexpressed at low dissolved oxygen (D.O.) levels, suggesting that the sigB operon is somewhat affected by the energy charge of the cells. The expression of SAK at the 10% D.O. level was three times higher than that at the 50% D.O. level. In the case of sacB, a sucrose-inducible promoter, sucrose feeding was used to control the induction period and induction strength. Since sucrose is hydrolyzed by two sucrose hydrolyzing enzymes in the cell and culture broth, the control strategy was based on replenishing the loss of sucrose in the culture. With continuous feeding of sucrose, WB700 (pSAKBQ), which contains the SAK gene under sacB promoter, yielded ca. 35% more SAK than the batch culture. These results present efficient promoter-dependent control strategies in B. subtilis host system for foreign protein expression.

• KSBB Journal
• /
• 제16권4호
• /
• pp.415-419
• /
• 2001

Bacillus subtilis WB700에서 P43 프로모터를 사용하여 staphylokinase를 생산하기 위하여 배지 최적화 및 회분식 배양과 유가식 배양 두가지 시스템을 비교하였다. 여러 가지 질소윈 중에서는 tryptone이 가장 좋은 질소원 이었으며, MSR 배지를 사용한 경우 tryptone 15 g/L일 경우에 최적조건임을 알아내었다. MSR 배지에시 포도당을 제한 기질로 사용할 경우는 5 g/L일 때가 SAK의 발현에 최적 조건이었다. MSR 배지를 기본으로 이용하여 포도당 공급을 조절함으로서 발효조 내의 DO를 30%로 유지한 결과 오히려 MSR 배지를 이용하여 회분식 발효를 한 경우보다 좋지 못한 결과를 얻었으며, 이는 B. subtilis 숙주의 영양요구적 특이성과 P43 promoter의 stress 발생시 주 발현되는 특성 등에 기인한 것이라고 사료된다. MSR 배지를 이용하여 회분식 발효를 하였을 때 SAK 활성은 2880 unit이었고, 이때 배지 내로 분비된 SAK 농도는 455 mg/L이었다.

• Journal of Microbiology and Biotechnology
• /
• 제22권7호
• /
• pp.894-901
• /
• 2012

Based on their respective antitumor and thrombolytic activities, the superantigen staphylococcal enterotoxin C2 (SEC2) and staphylokinase (Sak) were chosen for the construction of the novel chimeric proteins Sak-linker-SEC2 and SEC2-linker-Sak using a linker composed of nine Ala residues. Both chimeric proteins possessed nearly the same PBMC proliferation stimulating activity and antitumor activity as SEC2 and thrombolytic activity as Sak. Neither the SEC2 or Sak component of each chimeric protein affected the activity of the other component. The results presented in this study provide a possible strategy to prevent and cure tumor thrombus.